Clinical trial
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
NCT00418145 · Fred Lublin, Other · Terminated
Key facts
| NCT number | NCT00418145 |
|---|---|
| Title | Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks |
| Official title | Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA) |
| Lead sponsor | Fred Lublin, Other |
| Collaborators | National Multiple Sclerosis Society Pfizer Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | megadose oral methylprednisolone, IV methylprednisolone |
| Enrollment | 16 |
| Start date | Sep 1, 2003 |
| Primary completion | Oct 1, 2013 |
| Completion | Oct 1, 2013 |
| First posted | Jan 4, 2007 |
| Last update posted | May 18, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: